
Join to View Full Profile
10 Center DrBethesda, MD 20892
Phone+1 301-272-0628
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jessica Durkee-Shock, MD is a board certified pediatrician in Bethesda, Maryland. She is currently licensed to practice medicine in District of Columbia.
Education & Training
- University of MarylandResidency, Internal Medicine, 2013 - 2016
- University of MarylandResidency, Internal Medicine/Pediatrics, 2013 - 2016
- University of Maryland School of MedicineClass of 2012
Certifications & Licensure
- DC State Medical License 2018 - 2024
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- Reconstitution of Norovirus-Specific T-Cell Responses Following Hematopoietic Stem Cell Transplantation in Patients With Inborn Errors of Immunity and Chronic Noroviru...Jessica Durkee-Shock, Ariella Cohen, Naseem Maghzian, Gloria Pezzella, Mariah Jensen-Wachspress
The Journal of Infectious Diseases. 2025-03-17 - A Decade of Chronic Norovirus Infection Surveillance at the National Institutes of Health Clinical Research Center: Clinical Characteristics, Molecular Epidemiology, a...Natthawan Chaimongkol, Daniel Y Kim, Yuki Matsushima, Jessica Durkee-Shock, Karenna Barton
The Journal of Infectious Diseases. 2025-03-17 - 17 citationsImmunizing the imperfect immune system: Coronavirus disease 2019 vaccination in patients with inborn errors of immunity.Jessica R Durkee-Shock, Michael D Keller
Annals of Allergy, Asthma & Immunology. 2022-11-01
Press Mentions
- As Links to MS Deepen, Researchers Accelerate Efforts to Develop an Epstein-Barr VaccineOctober 19th, 2022
- SARS-CoV-2-Specific T-cell Responses Are Amplified in Children with Multisystem Inflammatory Syndrome in ChildrenAugust 27th, 2021